BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

Biotechnology

Healthcare
$1.86 -0.39%

-$0.03 today

Market cap
$149.27M
Beta
0.29
P/E (TTM)
-1.5
EPS (TTM)
-$4.95
52W Low $7.00High $14.87

Volume 0.37M

Average 0.37M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$145.82M

FY 2025 · Annual

Net Income

-$134.04M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development0056.29M73.11M121.2M
Selling, General & Admin43.36K3.52K8.49M7.76M24.62M
Operating Expenses43.36K3.52K64.77M80.86M145.82M
Depreciation & Amortization74.33K3.52K92K208K610K
EBITDA(43.36K)(3.52K)(64.68M)(80.66M)(145.21M)
EBITDA Margin—————
Operating Income(43.36K)(3.52K)(64.77M)(80.86M)(145.82M)
Operating Margin—————
Interest Income0072K8.46M11.34M
Interest Expense00000
Other Income / Expenses0072K8.18M11.78M
Income Before Tax(43.36K)(3.52K)(64.7M)(74.28M)(134.04M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(43.36K)(3.52K)(64.7M)(74.28M)(134.04M)
Net Margin—————
EPS (Basic)(0.00)0.00(3.16)0.46(4.30)
EPS (Diluted)(0.00)(0.00)(3.16)0.46(4.30)
Weighted Avg Shares20.49M20.49M20.49M16.64M31.14M
Weighted Avg Shares (Diluted)20.49M20.49M20.49M16.64M31.14M

BBOT Earnings Waterfall · TTM

NASDAQ:BBOT · Revenue to Net Income

Key Ratios

EPS$-5.71
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-2.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$154.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-5.71, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 23, 2026

How much revenue does BBOT generate?

BridgeBio Oncology Therapeutics Inc. (BBOT) reported $0.00 of revenue in fiscal 2025.

Is BBOT profitable?

BridgeBio Oncology Therapeutics Inc. (BBOT) reported -$134.04M of net income.